It can inhibit the growth of oral cancer cells by reducing specificity protein 1 (Sp1) and induce caspase-dependent apoptosis, suggesting that emodin may be a potential bioactive substance to induce apoptosis [74]. This evidence concerns the gene SP1 and lip and oral cavity carcinoma.